From 2013 the Federation will contribute two special issues to the journal annually, while representatives from the AFOB will join the editorial board.
Since launching in 2006 Biotechnology Journal has become a truly international title. Edited by Professor Sang Yup Lee, from KAIST University in South Korea, and Professor Alois Jungbauer from BOKU University in Austria, the journal attracts international authors, a global readership and will be awarded an official Impact Factor in 2013.
As a partner journal of the AFOB, the Biotechnology Journal will work with the Federation to disseminate scientific knowledge from Asian research communities to a global audience by dedicating special issues to research and breakthroughs on topics that are relevant to all biotechnologists.
A new “AFOB Highlights” section will also be introduced to the journal as a forum for reporting Federation news, announcements, prizes and awards. The AFOB will also contribute news and views to Wiley’s BiotecVisions e-magazine, which will be circulated to all Federation members on a monthly basis.
Biotechnology Journal will continue to collaborate with the European Federation of Biotechnology section on Biochemical Engineering, placing it in a unique position to serve as a bridge between European and Asian biotechnologists.
“Wiley’s mission is to bring the best of science to an international audience,” said Carol Bacchus, Vice President and Publishing Director, Life Sciences, Wiley. “This AFOB collaboration is a new milestone, which will foster greater international co-operation between Asian and non-Asian scientists to enhance our knowledge in all areas and applications of biotechnology and engineering technologies.”
“Working with Biotechnology Journal has always been a pleasurable and successful experience for the AFOB,” said Professor Ho Nam Chang, AFOB’s incoming president. “We are therefore delighted to have this official agreement, which will further promote research from Asia to an international audience.”
About the Journal
Biotechnology Journal (biotechnology-journal.com) was launched in 2006 as an international resource for both biotechnology researchers and professionals in related disciplines. Published by Wiley-VCH, a subsidiary of John Wiley & Sons, the journal is comprehensive in its scope, and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Special attention is also paid to the public, legal, ethical and cultural aspects of biotechnological research in the Forum section. Most issues are devoted to a special topic, providing the latest comprehensive information on the most crucial areas of research and technological advances.
About the Asian Federation of Biotechnology (AFOB)
Asian Federation of Biotechnology (afob.org) is a non-profit organization established in 2008. Its incorporation was agreed upon by the delegates from Asian countries during the IBS 2008 conference, Oct. 12-17 held in Dalian, China. The federation promotes co-operation between scientists from academia and industry across Asia to advance the fields of biotechnology and sustainable development. The federation also seeks to educate and promote awareness of biotechnology to the public.
Founded in 1807, John Wiley & Sons, Inc. (wiley.com) has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace.
Our core businesses publish scientific, technical, medical, and scholarly journals, encyclopedias, books, and online products and services; professional/trade books, subscription products, training materials, and online applications and Websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.